ClinicalTrials.gg
RecruitingNCT07212699KneeAppUpdated Apr 6, 2026

Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an App

An interventional study of KneeApp in Knee Osteoarthritis, Knee Arthroplasty and Hip Osteoarthritis, sponsored by Technical University of Munich. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Technical University of Munich · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,250
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Osteoarthritis, Knee with a site in Germany — 3 open to participants now, 8 under way, 1 of them phase 3. Osteoarthritis, Knee · Germany.

Planned enrollment
5th of 49
1,250 · median 140
Started
2025
with 1 other
No phase
20 of 64
1 open now
Registered
63rd of 64
by date

Among the 64 studies in Osteoarthritis, Knee with a site in Germany, this one is the 5th largest by planned enrollment of the 49 interventional ones that give a count, is one of 2 that started in 2025, is one of 20 with no phase, and was the 63rd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

3 of the 64 studies in Osteoarthritis, Knee with a site in Germany are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Osteoarthritis, Knee with a site in Germany, or all of them as a file.
02

Study summary

Total knee arthroplasty (TKA) and total hip arthroplasty (THA) is one of the most frequent orthopedic procedures. Over 50% of patients report higher expectations than their surgeons, and 10-50% remain dissatisfied postoperatively. Persistent pain, functional limitations, and unmet expectations are key drivers. Identifying risks pre- and early postoperatively is essential, alongside empowering patients through self-management.

Existing scoring systems integrate PROMs, demographics, and sometimes imaging but within limited timeframes. They rarely capture functional deficits or long-term trajectories. Digital health solutions for TKA (pre-)rehabilitation exist, yet most focus on physiotherapy and education rather than predictive outcome modeling.

To address this gap, the study team has developed a novel mobile application that enables the documentation and analysis of movement data up to 10 years before surgery and throughout long-term follow-up. These data are combined with PROMs and functional test results, providing a unique basis for outcome prediction and risk stratification in TKA/THA.

Primary Objective The aim of this pilot study is to develop a composite outcome score for TKA/THA patients. This score will integrate demographic variables, PROMs, and objective functional measures (knee joint angles, gait parameters, walk tests) to identify risk factors for dissatisfaction and support predictive modeling. A machine learning algorithm will be trained using the collected dataset to predict patient satisfaction after TKA/THA.

Endpoints Primary endpoint: Overall patient satisfaction Secondary endpoints: Age, height, weight, step count, step length, gait asymmetry, gait speed, double support phase, knee joint ROM, walk test, KOOS, SF-36, EQ5d, satisfaction with the app, and satisfaction with app use.

Study Population App-Group: Inclusion criteria are patients ≥18 years before or after TKA/THA. Exclusion criteria include missing consent, ineligible diagnosis, lack of smartphone, age \<18 years, or insufficient German language skills (as no English version of the app is currently available). Planned enrollment: 450 patients.

Non-App-Group: Inclusion criteria are patients ≥18 years before or after TKA/THA. Exclusion criteria include missing consent, ineligible diagnosis, age \<18 years, or insufficient German language skills (as no English version of the app is currently available). Planned enrollment: 450 patients.

Healthy-group: Inclusion criteria are healthy proband ≥18 years with no lower limb conditions. The overall procedure is identical to that of the AppGroup. Exclusion criteria include missing consent, ineligible diagnosis, no smartphone, age \<18 years, or insufficient German language skills (as no English version of the app is currently available). Planned enrollment: 450 patients.

Methods Design: Single-center, prospective pilot study. The app collects patient-authorized movement data already stored on smartphones as well as future data. Participants choose which data to share. In addition, they are prompted to complete gait tests and knee function tests. PROMs (KOOS, SF-36, satisfaction) are administered at regular intervals.

Read the detailed description

Background:

In routine medical practice, only limited objective long-term data on patients' physical activity and its progression during the course of disease are typically available. Similarly, longitudinal information from patient-reported outcome measures (PROMs) or functional tests is often lacking. In musculoskeletal disorders in particular, combining subjective complaints with data on patients' everyday movement behavior is crucial for guiding further diagnostic or therapeutic decisions and for risk assessment.

Following total knee arthroplasty (TKA), more than 50% of patients report higher expectations for their surgical outcome than their treating surgeons. Between 10% and 50% of patients remain dissatisfied with the overall outcome after TKA/THA. Persistent pain is among the main reasons for such dissatisfaction. Functional musculoskeletal limitations and unmet expectations regarding the outcome further contribute to long-term dissatisfaction. Additional risk factors for an unsatisfactory outcome include younger age, female sex, higher BMI, limited radiographic severity of osteoarthritis preoperatively (likely reflecting minor functional deficits), and psychological factors such as catastrophizing, depression, and anxiety.

To sustainably improve patient satisfaction, these risk factors must be identified and analyzed both preoperatively and in the early postoperative period, and the results must be communicated clearly to patients and healthcare providers. Patient self-management plays an essential role in this context. Patients should be empowered to actively improve their postoperative outcomes by addressing modifiable risk factors through targeted self-directed strategies.

Existing scoring systems generally focus on integrating clinical parameters such as PROMs, demographic data, and, in some cases, imaging within limited timeframes. However, they usually do not incorporate musculoskeletal functional deficits or long-term continuous pre- and postoperative trajectories.

With the ongoing digitalization of medicine, various systems for prehabilitation and rehabilitation in the context of TKA/THA are already available.

Current systems for digital prehabilitation and rehabilitation generally focus on physiotherapeutic self-exercises and patient education regarding the pre- and postoperative disease course, but they do not address outcome prediction.

Primary Objective of the Pilot Study The primary objective of this pilot study is the development of an outcome score for patients before and after TKA/THA using a self-developed app. This score will combine demographic and subjective parameters (PROMs) with objective functional parameters (knee joint angle measurement, gait parameters, and the 6-minute walk test) to provide the most comprehensive picture possible of risk factors and deficits associated with patient dissatisfaction.

Based on the collected data, a machine learning algorithm will be developed to predict outcomes with respect to patient satisfaction.

Null hypothesis (H₀):

A combined score consisting of demographic data, PROMs (Patient-Reported Outcome Measures), and objective functional parameters (knee joint angle, gait parameters, walk test) does not allow significant prediction of postoperative patient satisfaction after TKA/THA at different time points.

Alternative hypothesis (H₁):

A combined score consisting of demographic data, PROMs, and objective functional parameters does allow significant prediction of postoperative patient satisfaction after THA/TKA at different time points.

Endpoints / Outcome Measures Primary endpoint: Overall satisfaction with clinical course Secondary endpoints: Age, height, weight, step count, step length, gait asymmetry, gait speed, double support phase, knee joint ROM, walk test, satisfaction with app, KOOS, SF-36, EQ5d

Study Population App-Group: Inclusion criteria: All patients over 18 years of age before and after implantation of a knee/hip joint arthroplasty, or with gon/hip osteoarthritis alone. Exclusion criteria: Missing informed consent; diagnosis not meeting the inclusion criteria; no smartphone with iOS operating system; non-German speaking; age \<18 years. Handling of non-German-speaking individuals: Since no English version of the app is currently available, non-German-speaking individuals cannot participate in the study. Planned number of participants: 450 patients

Non-App-Group: Inclusion criteria are patients ≥18 years before or after TKA/THA not using the study-app. Exclusion criteria include missing consent, ineligible diagnosis, age \<18 years, or insufficient German language skills (as no English version of the app is currently available). Planned enrollment: 450 patients.

Healthy-group: Inclusion criteria are healthy proband ≥18 years with no lower limb conditions. The overall procedure is identical to that of the AppGroup. Exclusion criteria include missing consent, ineligible diagnosis, no smartphone, age \<18 years, or insufficient German language skills (as no English version of the app is currently available). Planned enrollment: 450 patients.

Recruitment measures:

Recruitment will be conducted via flyers and posters displayed in the routine arthroplasty outpatient clinic of the Department of Orthopaedics and Sports Orthopaedics. Patients can download the app using a QR code provided in the information materials.

Access to the app is granted during the outpatient visit at the Department of Orthopaedics and Sports Orthopaedics once the patient consents to participate in the study. Written informed consent is obtained by the attending physicians of the Department of Orthopaedics and Sports Orthopaedics at TUM University Hospital, who will have received detailed training from the study leadership. Participants may contact the study team at any time with questions. Additionally, a help tool will be integrated into the app for patient inquiries and feedback.

No financial compensation will be provided to participants. No insurance has been taken out for participants.

Methodology and Implementation Study design: Single-center, prospective pilot study

Study procedure:

App-/Healthy-Group: The app collects patient-authorized movement data and analyzes these data. Participants may select which data they wish to share.

In addition, participants are prompted at regular intervals to perform and document functional tests, such as gait tests and knee function tests. Standardized PROMs (KOOS, SF-36, satisfaction) are collected at regular intervals.

Data collection begins immediately after app installation and ends at the latest two years after initiation of data collection.

Non-App-Group: in this arm, patients with osteoarthritis or those who have undergone TKA/THA surgery are included without using the app. These patients receive the same questionnaires as the app group by post, with a request to complete and return them. The patients do not need to play any further active role in the study.

Description of Data Sources

The data used in this study are derived from two main sources:

  1. movement data provided by the participants' mobile devices (e.g., step count, step length, gait speed, knee joint angle, etc.), which are integrated into the app following the users' explicit consent; and
  2. subjective health data collected at regular intervals via standardized questionnaires integrated into the app (e.g., KOOS, SF-36, EQ5d, satisfaction).

The app accesses only those movement data supplied by the operating system and explicitly released by the user. Data processing occurs solely with the participants' active consent for each respective data category.

The selection and processing of these data sources have been coordinated with the Data Protection Officer of TUM University Hospital and have undergone a formal data protection assessment. All applicable data protection requirements are fully observed, particularly with respect to pseudonymization, data security, and purpose limitation.

Data Management and Data Protection In this study, the University Hospital of the Technical University of Munich (TUM Klinikum), Ismaninger Straße 22, 81675 Munich, is responsible for data processing. The legal basis for processing is the personal consent of participants in accordance with Art. 6(1)(a) and Art. 9(2)(a) GDPR. All data will be treated confidentially at all times.

Access to the collected data is restricted to authorized members of the study team. Data will only be stored as long as necessary for the conduct and scientific evaluation of the study, but for no longer than 10 years after study completion. Participation in the study and consent to data processing are voluntary. Participants may withdraw their consent at any time without providing reasons and without any disadvantage to themselves.

03

Conditions studied

  • Knee Osteoarthritis
  • Knee Arthroplasty
  • Hip Osteoarthritis
  • Hip Arthroplasty

Keywords

  • knee
  • app
  • arthroplasty
  • detection
  • risk score
  • hip
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18 years or older
  • german speaking
  • signed
  • using own smartphone

Exclusion criteria

Exclusion criteria:

  • age below 18 years.
  • Lack of
  • no smartphone
  • non-German-speaking
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,250 participants (estimated)

Study arms

  • Experimental
    App-Group

    Group which is using the app before and after TKA

    Other: KneeApp

  • No intervention
    Non-App Group

    In this arm, patients with osteoarthritis or those who have undergone TKA/THA surgery are included without using the app. These patients receive the same questionnaires as the app group by post, with a request to complete and return them. The patients do not need to play any further active role in the study.

  • Active comparator
    Healthy controls

    In this arm, healthy participants with no lower limb conditions are given the app. This group receives the same questionnaires as all other groups and completes the gait tests in the same way as the app group comprising patients with the condition. The overall procedure is identical to that of the app group comprising patients with the condition.

    Other: KneeApp

Interventions

  • OtherKneeApp

    Our app collects patient-authorized mobility data that are already stored on the patient's smartphone and those that will be recorded in the future, and analyzes these data with respect to their temporal patterns. Each study participant can decide individually which data they wish to share. In addition, participants are prompted at regular intervals to perform and document functional tests, such as gait assessments (once per month) and knee function tests (weekly). Furthermore, subjective health data are regularly collected using standardized PROMs: KOOS and SF-36 every three weeks, patient-reported satisfaction with health status on a monthly basis, and user satisfaction with the app every three months. The collected data can be accessed both by the patient and the study team and can be downloaded and stored as a PDF file if needed. Participation in the study requires a single on-site visit at the Department and Outpatient Clinic of Orthopedics and Sports Orthopedics. No further in-pe

06

What researchers measure

Primary outcomes

  1. overall patient satisfaction

    satisfaction scale minimum: 0 = not satisfied, maximum: 5 = fully satisfied

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. age

    age in years

    Time frame: through study completion, an average of 1 year

  2. sex

    sex in male, female, diverse

    Time frame: through study completion, an average of 1 year

  3. height

    height in centimeters

    Time frame: through study completion, an average of 1 year

  4. Weight

    weight in kilograms, weight and height will be combined to report BMI in kg/m\^2

    Time frame: through study completion, an average of 1 year

  5. KOOS

    The KOOS (Knee injury and Osteoarthritis Outcome Score) is a 42-item, patient-reported questionnaire assessing knee-related symptoms, pain, activities of daily living, sport/recreation, and quality of life, with scores ranging from 0 (extreme problems) to 100 (no problems).

    Time frame: through study completion, an average of 1 year

  6. SF-36

    The SF-36 is a 36-item, patient-reported questionnaire assessing health-related quality of life across eight domains, with scores ranging from 0 (worst health) to 100 (best health).

    Time frame: through study completion, an average of 1 year

  7. Knee range of motion

    The test measures knee joint mobility in degrees from -10° to 130°.

    Time frame: through study completion, an average of 1 year

  8. 2-Minute walking test

    The test measures the distance walked in meters in 2 minutes.

    Time frame: through study completion, an average of 1 year

  9. App feedback

    The questionnaire contains three questions about satisfaction with the app and allows for free comments on wishes and suggestions.

    Time frame: through study completion, an average of 1 year

  10. step count

    Measures the number of steps in absolute numbers per day

    Time frame: through study completion, an average of 1 year

  11. stride length

    Measures stride length in meters

    Time frame: through study completion, an average of 1 year

  12. gait speed

    Measures walking speed in meters per second

    Time frame: through study completion, an average of 1 year

  13. double stance phase

    The double stance phase is measured by the iPhone's inertial sensors using gait cycle algorithms and expressed as a percentage of total gait cycle time (%).

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Department of Orthopaedics and Sports Orthopaedics TUM University Hospital Rechts der Isar
    Munich, Bavaria 81675, Germany
    Recruiting
    • Christina Valle, Dr. med. · Contactchristina.valle@tum.de · +498941406508
    • Ricardo Smits Serena, M Sc · Sub investigator
    • Florian Hinterwimmer, Dr.rer. nat. · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) collected in this trial will not be shared due to data protection and privacy regulations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Dec 2026, 14 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 14 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2025
First posted
Oct 8, 2025
StartActual
Oct 1, 2025
Primary completionEst.
Dec 30, 2026
CompletionEst.
Aug 31, 2028
Last update
Apr 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07212699
Responsible party
Christina Valle (Dr. med., Technical University of Munich) — Principal investigator
First posted
Oct 8, 2025
Start date
Oct 1, 2025
Primary completion
Dec 30, 2026 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Apr 6, 2026

Study contacts

Christina Valle, Dr. med
Contact
christina.valle@tum.de
+498941406508
Florian Hinterwimmer, Dr. rer. nat.
Contact
florian.hinterwimmer@tum.de
Rüdiger von Eisenhart-Rothe, Univ.-Prof. Dr. med.
study director · Department of Orthopaedics and Sports Orthopaedics, TUM University Hospital Rechts der Isar

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion